CA2309258A1 - Nutritive media and manufactured seeds comprising same - Google Patents
Nutritive media and manufactured seeds comprising same Download PDFInfo
- Publication number
- CA2309258A1 CA2309258A1 CA002309258A CA2309258A CA2309258A1 CA 2309258 A1 CA2309258 A1 CA 2309258A1 CA 002309258 A CA002309258 A CA 002309258A CA 2309258 A CA2309258 A CA 2309258A CA 2309258 A1 CA2309258 A1 CA 2309258A1
- Authority
- CA
- Canada
- Prior art keywords
- manufactured seed
- nutritive medium
- medium further
- hcl
- manufactured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000050 nutritive effect Effects 0.000 title claims abstract 45
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract 22
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract 22
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract 22
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims abstract 18
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract 16
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract 11
- 239000007836 KH2PO4 Substances 0.000 claims abstract 11
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract 11
- 150000001413 amino acids Chemical class 0.000 claims abstract 11
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims abstract 11
- 229910052799 carbon Inorganic materials 0.000 claims abstract 11
- 229960000367 inositol Drugs 0.000 claims abstract 11
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract 11
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract 11
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract 11
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract 11
- 235000019796 monopotassium phosphate Nutrition 0.000 claims abstract 11
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract 11
- 229960003512 nicotinic acid Drugs 0.000 claims abstract 11
- 239000011664 nicotinic acid Substances 0.000 claims abstract 11
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims abstract 11
- 235000008160 pyridoxine Nutrition 0.000 claims abstract 11
- 239000011677 pyridoxine Substances 0.000 claims abstract 11
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract 11
- 235000019157 thiamine Nutrition 0.000 claims abstract 11
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract 11
- 229960003495 thiamine Drugs 0.000 claims abstract 11
- 239000011721 thiamine Substances 0.000 claims abstract 11
- 229940011671 vitamin b6 Drugs 0.000 claims abstract 11
- 102000004169 proteins and genes Human genes 0.000 claims abstract 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract 10
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract 10
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract 10
- 239000011686 zinc sulphate Substances 0.000 claims abstract 10
- 235000009529 zinc sulphate Nutrition 0.000 claims abstract 10
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 claims abstract 9
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract 9
- 239000003610 charcoal Substances 0.000 claims abstract 9
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract 9
- 229910000366 copper(II) sulfate Inorganic materials 0.000 claims abstract 9
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims abstract 9
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims abstract 9
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims abstract 9
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 claims abstract 9
- 235000010333 potassium nitrate Nutrition 0.000 claims abstract 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract 8
- 229910004619 Na2MoO4 Inorganic materials 0.000 claims abstract 8
- 229960002685 biotin Drugs 0.000 claims abstract 8
- 235000020958 biotin Nutrition 0.000 claims abstract 8
- 239000011616 biotin Substances 0.000 claims abstract 8
- 229960000304 folic acid Drugs 0.000 claims abstract 8
- 235000019152 folic acid Nutrition 0.000 claims abstract 8
- 239000011724 folic acid Substances 0.000 claims abstract 8
- 229940014662 pantothenate Drugs 0.000 claims abstract 8
- 239000011713 pantothenic acid Substances 0.000 claims abstract 8
- 229960002477 riboflavin Drugs 0.000 claims abstract 8
- 235000019192 riboflavin Nutrition 0.000 claims abstract 8
- 239000002151 riboflavin Substances 0.000 claims abstract 8
- 235000015393 sodium molybdate Nutrition 0.000 claims abstract 8
- 239000011684 sodium molybdate Substances 0.000 claims abstract 8
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 claims abstract 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract 7
- 239000004202 carbamide Substances 0.000 claims abstract 7
- 229910019934 (NH4)2MoO4 Inorganic materials 0.000 claims abstract 6
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 claims abstract 6
- 229960002413 ferric citrate Drugs 0.000 claims abstract 6
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims abstract 6
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims abstract 5
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims abstract 5
- 239000011565 manganese chloride Substances 0.000 claims abstract 5
- 235000002867 manganese chloride Nutrition 0.000 claims abstract 5
- 229920000768 polyamine Polymers 0.000 claims abstract 5
- 239000000779 smoke Substances 0.000 claims abstract 5
- 239000000725 suspension Substances 0.000 claims abstract 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 12
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 12
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 12
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 12
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 12
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 12
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 12
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 11
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 9
- 229940024606 amino acid Drugs 0.000 claims 9
- 235000001014 amino acid Nutrition 0.000 claims 9
- 239000001110 calcium chloride Substances 0.000 claims 9
- 235000011148 calcium chloride Nutrition 0.000 claims 9
- 229910001628 calcium chloride Inorganic materials 0.000 claims 9
- 229930006000 Sucrose Natural products 0.000 claims 8
- 235000018102 proteins Nutrition 0.000 claims 8
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims 8
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 claims 8
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 claims 8
- 239000005720 sucrose Substances 0.000 claims 8
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 6
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 6
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims 6
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 6
- 229930064664 L-arginine Natural products 0.000 claims 6
- 235000014852 L-arginine Nutrition 0.000 claims 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 6
- 229930182816 L-glutamine Natural products 0.000 claims 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 6
- 229930182844 L-isoleucine Natural products 0.000 claims 6
- 235000019454 L-leucine Nutrition 0.000 claims 6
- 239000004395 L-leucine Substances 0.000 claims 6
- 229930182821 L-proline Natural products 0.000 claims 6
- 239000004473 Threonine Substances 0.000 claims 6
- 229960003767 alanine Drugs 0.000 claims 6
- 229960001230 asparagine Drugs 0.000 claims 6
- 229960002885 histidine Drugs 0.000 claims 6
- 229960000310 isoleucine Drugs 0.000 claims 6
- 229960003136 leucine Drugs 0.000 claims 6
- 229960002429 proline Drugs 0.000 claims 6
- 229960001153 serine Drugs 0.000 claims 6
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims 6
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims 6
- 229960002898 threonine Drugs 0.000 claims 6
- 229960004441 tyrosine Drugs 0.000 claims 6
- 229960004295 valine Drugs 0.000 claims 6
- 229910021592 Copper(II) chloride Inorganic materials 0.000 claims 5
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 5
- 229930195722 L-methionine Natural products 0.000 claims 5
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims 5
- 229960004452 methionine Drugs 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 4
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 4
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 4
- 239000005700 Putrescine Substances 0.000 claims 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 4
- 229960003104 ornithine Drugs 0.000 claims 4
- 229940063673 spermidine Drugs 0.000 claims 4
- 229940063675 spermine Drugs 0.000 claims 4
- 125000000185 sucrose group Chemical group 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 3
- 230000008635 plant growth Effects 0.000 claims 2
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims 1
- 229960002743 glutamine Drugs 0.000 claims 1
- -1 CaC12 Chemical compound 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/005—Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
- A01H4/006—Encapsulated embryos for plant reproduction, e.g. artificial seeds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Environmental Sciences (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Manufactured seeds are disclosed that comprise a unit of totipotent plant tissue and a nutritive medium. The nutritive medium can contain a number of different components selected from the following: a gel solute, charcoal, a carbon source, urea, KNO3, NH4NO3, CuC12, CuSO4, KI, KH2PO4, CaC12, MgSO4, Na2EDTA, FeSO4, ferric citrate, MnSO4, MnCl2, H3BO3, ZnSO4, CoCl2, Na2MoO4, (NH4)2MoO4, thiamine, riboflavin, pyridoxine. HCl, Ca-pantothenate, nicotinic acid, biotin, folic acid, and myo-inositol. The nutritive medium can also include any of various protein amino acids, any of various polyamines, any of various oxygen-absorbing compounds, any of various non-protein amino acids, and/or a smoke suspension.
Claims (47)
1. A manufactured seed, comprising:
(a) a unit of totipotent plant tissue; and (b) a nutritive medium comprising at least 15 components selected from the group consisting of: 0 g/L to 30 g/L gel solute, 5 mM to 200 mM carbon source, 0 mM
to 20 mM
KNO3, 2.5 mM to 5 mM NH4NO3, 0 mM to 0.01 mM KI, 0.01 mM to 20 mM KH2PO4, 0.5 mM
to 5 mM CaCl2, 0 mM to 0.0001 mM CuSO4, 0.1 mM to 10 mM MgSO4, 0 mM to 0.1 mM
Na2EDTA, 0 mM to 0.1 mM FeSO4, 0 mM to 0.1 mM MnSO4, 0.01 mM to 1 mM H3BO3, 0.0001 mM to 0.005 mM ZnSO4, 0 mM to 0.0001 mM CoCl2, 0 mM to 0.001 mM NaiMoO4, 0 mM
to 0.01 mM thiamine.HCl, 0.001 mM to 0.005 mM pyridoxine.HCl, 0.001 mM to 0.02 mM
nicotinic acid, 0.05 mM to 2.5 mM myo-inositol, and 0.002 mM to 0.2 mM L-glycine.
(a) a unit of totipotent plant tissue; and (b) a nutritive medium comprising at least 15 components selected from the group consisting of: 0 g/L to 30 g/L gel solute, 5 mM to 200 mM carbon source, 0 mM
to 20 mM
KNO3, 2.5 mM to 5 mM NH4NO3, 0 mM to 0.01 mM KI, 0.01 mM to 20 mM KH2PO4, 0.5 mM
to 5 mM CaCl2, 0 mM to 0.0001 mM CuSO4, 0.1 mM to 10 mM MgSO4, 0 mM to 0.1 mM
Na2EDTA, 0 mM to 0.1 mM FeSO4, 0 mM to 0.1 mM MnSO4, 0.01 mM to 1 mM H3BO3, 0.0001 mM to 0.005 mM ZnSO4, 0 mM to 0.0001 mM CoCl2, 0 mM to 0.001 mM NaiMoO4, 0 mM
to 0.01 mM thiamine.HCl, 0.001 mM to 0.005 mM pyridoxine.HCl, 0.001 mM to 0.02 mM
nicotinic acid, 0.05 mM to 2.5 mM myo-inositol, and 0.002 mM to 0.2 mM L-glycine.
2. The manufactured seed of claim 1, wherein the nutritive medium further comprises 0 to 5 g/L charcoal.
3. The manufactured seed of claim 1, wherein the carbon source is sucrose.
4. The manufactured seed of claim 1, wherein the nutritive medium further comprises an amino acid selected from the group consisting of: L-asparagine, L-glutamine, L-lysine, L-serine, L-proline, L-arginine, L-valine, L-alanine, L-cysteine, L-leucine, L-tyrosine, L-threonine, L-phenylalanine, L-histidine, L-tryptophan, L-isoleucine, L-methionine, and mixtures thereof.
5. The manufactured seed of claim 1, wherein the nutritive medium further comprises a smoke suspension.
6. The manufactured seed of claim 1, wherein the nutritive medium further comprises urea.
7. The manufactured seed of claim 1, wherein the nutritive medium further comprises a non-protein amino acid.
8. The manufactured seed of claim 7, wherein the non-protein amino acid is ornithine.
9. The manufactured seed of claim 1, wherein the nutritive medium further comprises a polyamine selected from the group consisting of putrescine, spermidine, spermine, and mixtures thereof.
10. The manufactured seed of claim 1, wherein the nutritive medium further comprises riboflavin.
11. The manufactured seed of claim 1, wherein the nutritive medium further comprises Ca-pantothenate.
12. The manufactured seed of claim 1, wherein the nutritive medium further comprises biotin.
13. The manufactured seed of claim 1, wherein the nutritive medium further comprises folic acid.
14. The manufactured seed of claim 1, wherein the nutritive medium further comprises an oxygen-absorbing substance.
15. The manufactured seed of claim 1, wherein the nutritive medium comprises:
58.43 mM sucrose, 11.57 mM KNO3, 2.577 mM NH4NO3, 0.0025 mM KI, 0.625 mM KH2PO4, 1.133 mM CaCl2, 3.2x10-5 mM CuSO4, 0.367 mM MgSO4, 0.05 mM Na2EDTA, 0.027 mM FeSO4, 0.045 mM MnSO4, 0.05 mM H3BO3, 8.4x10-3 mM ZnSO4, 2.9x10-5 mM CoCl2, 4.4x10-4 mM
Na2MoO4, 0.003 mM thiamine.HCl, 0.0024 mM pyridoxine.HCl, 0.0041 mM nicotinic acid, 0.555 mM myo-inositol, and 0.027 mM L-glycine.
58.43 mM sucrose, 11.57 mM KNO3, 2.577 mM NH4NO3, 0.0025 mM KI, 0.625 mM KH2PO4, 1.133 mM CaCl2, 3.2x10-5 mM CuSO4, 0.367 mM MgSO4, 0.05 mM Na2EDTA, 0.027 mM FeSO4, 0.045 mM MnSO4, 0.05 mM H3BO3, 8.4x10-3 mM ZnSO4, 2.9x10-5 mM CoCl2, 4.4x10-4 mM
Na2MoO4, 0.003 mM thiamine.HCl, 0.0024 mM pyridoxine.HCl, 0.0041 mM nicotinic acid, 0.555 mM myo-inositol, and 0.027 mM L-glycine.
16. A manufactured seed, comprising:
(a) a unit of totipotent plant tissue; and (b) a nutritive medium comprising at least 15 components selected from the group consisting of: 0 g/L to 30 g/L gel solute, 0 g/L to 5 g/L charcoal, 5 mM to 200 mM carbon source, 0 mM to 30 mM urea, 0 mM to 20 mM KNO3, 2.5 mM to 5 mM NH4NO3, 0 mM to 0.01 mM KI, 0.01 mM to 20 mM KH2PO4, 0.5 mM to 5 mM CaCl2, 0.1 mM to 10 mM MgSO4, 0 mM
to 0.1 mM Na2EDTA, 0 mM to 0.1 mM FeSO4, 0 mM to 0.5 mM ferric citrate, 0 mM
to 0.1 mM
MnSO4, 0 mM to 0.1 mM MnCl2, 0.01 mM to 1 mM H3BO3, 0.0001 mM to 0.005 mM
ZnSO4, 0 mM to 0.0001 mM CoCl2, 0 mM to 0.0001 mM CuSO4, 0 mM to 0.005 mM CuCl2, 0 mM
to 0.001 mM Na2MoO4, 0 mM to 0.001 mM (NH4)2MoO4, 0 mM to 0.01 mM thiamine.HCl, 0 mM to 0.001 mM riboflavin, 0.001 mM to 0.005 mM pyridoxine.HCl, 0 mM to 0.04 mM
Ca-pantothenate, 0.001 mM to 0.02 mM nicotinic acid, 0 mM to 1.0x10-5 mM
biotin, 0 mM to 0.001 mM folic acid, 0.05 mM to 2.5 mM myo-inositol; and at least 1 component selected from the group consisting of: 0 mM to 2 mM L-asparagine, 0 mM to 6 mM L-glutamine, 0 mM
to 2 mM
L-lysine, 0 mM to 2 mM L-serine, 0 mM to 2 mM L-proline, 0 mM to 8 mM L-arginine, 0 mM to 2 mM L-valine, 0 mM to 2 mM L-alanine, 0 mM to 2 mM L-cysteine, 0 mM to 2 mM L-leucine, 0 mM to 2 mM L-tyrosine, 0 mM to 2 mM L-threonine, 0 mM to 2 mM L-phenylalanine, 0 mM to 2 mM L-histidine, 0.002 mM to 0.2 mM L-glycine, 0 mM to 2 mM L-tryptophan, 0 mM to 2 mM
L-isoleucine, and 0 mM to 2 mM L-methionine.
(a) a unit of totipotent plant tissue; and (b) a nutritive medium comprising at least 15 components selected from the group consisting of: 0 g/L to 30 g/L gel solute, 0 g/L to 5 g/L charcoal, 5 mM to 200 mM carbon source, 0 mM to 30 mM urea, 0 mM to 20 mM KNO3, 2.5 mM to 5 mM NH4NO3, 0 mM to 0.01 mM KI, 0.01 mM to 20 mM KH2PO4, 0.5 mM to 5 mM CaCl2, 0.1 mM to 10 mM MgSO4, 0 mM
to 0.1 mM Na2EDTA, 0 mM to 0.1 mM FeSO4, 0 mM to 0.5 mM ferric citrate, 0 mM
to 0.1 mM
MnSO4, 0 mM to 0.1 mM MnCl2, 0.01 mM to 1 mM H3BO3, 0.0001 mM to 0.005 mM
ZnSO4, 0 mM to 0.0001 mM CoCl2, 0 mM to 0.0001 mM CuSO4, 0 mM to 0.005 mM CuCl2, 0 mM
to 0.001 mM Na2MoO4, 0 mM to 0.001 mM (NH4)2MoO4, 0 mM to 0.01 mM thiamine.HCl, 0 mM to 0.001 mM riboflavin, 0.001 mM to 0.005 mM pyridoxine.HCl, 0 mM to 0.04 mM
Ca-pantothenate, 0.001 mM to 0.02 mM nicotinic acid, 0 mM to 1.0x10-5 mM
biotin, 0 mM to 0.001 mM folic acid, 0.05 mM to 2.5 mM myo-inositol; and at least 1 component selected from the group consisting of: 0 mM to 2 mM L-asparagine, 0 mM to 6 mM L-glutamine, 0 mM
to 2 mM
L-lysine, 0 mM to 2 mM L-serine, 0 mM to 2 mM L-proline, 0 mM to 8 mM L-arginine, 0 mM to 2 mM L-valine, 0 mM to 2 mM L-alanine, 0 mM to 2 mM L-cysteine, 0 mM to 2 mM L-leucine, 0 mM to 2 mM L-tyrosine, 0 mM to 2 mM L-threonine, 0 mM to 2 mM L-phenylalanine, 0 mM to 2 mM L-histidine, 0.002 mM to 0.2 mM L-glycine, 0 mM to 2 mM L-tryptophan, 0 mM to 2 mM
L-isoleucine, and 0 mM to 2 mM L-methionine.
17. The manufactured seed of claim 16, wherein the nutritive medium further comprises 0 to 5 g/L charcoal.
18. The manufactured seed of claim 16, wherein the nutritive medium further comprises a non-protein amino acid.
19. The manufactured seed of claim 18, wherein the non-protein amino acid is ornithine.
20. The manufactured seed of claim 16, wherein the carbon source is sucrose.
21. The manufactured seed of claim 16, wherein the nutritive medium further comprises a smoke suspension.
22. The manufactured seed of claim 16, wherein the nutritive medium further comprises a polyamine selected from the group consisting of putrescine, spermidine, spermine, and mixtures thereof.
23. The manufactured seed of claim 16, wherein the nutritive medium further comprises an oxygen-absorbing substance.
24. A manufactured seed, comprising:
(a) a unit of totipotent plant tissue; and (h) a nutritive medium comprising 0 g/L to 30 g/L gel solute, 2.5 g/L
charcoal, 146.07 mM sucrose, 13.32 mM urea, 3.74 mM NH4NO3, 13.23 mM KH2PO4, 1.54 mM CaCl2, 1.98 mM
MgSO4, 0.245 mM ferric citrate, 0.162 mM H3BO3, 0.0023 mM CuCl2, 0.0003 mM
(NH4)2MoO4, 0.0012 mM thiamine.HCl, 0.0003 mM riboflavin, 0.0012 mM pyridoxine.HCl, 0.001 mM
Ca-pantothenate, 0.0081 mM nicotinic acid, 4.09x10-6 mM biotin, 0.0003 mM
folic acid, 0.555 mM
myo-inositol, 0.8076 mM L-asparagine, 1.8248 mM L-glutamine, 0.1624 mM L-lysine, 0.7613 mM L-serine, 0.463 mM L-proline, 1.0471 mM L-arginine, 0.455 mM L-valine, 0.5983 mM
L-alanine, 0.6099 mM L-cysteine, 0.6099 mM L-leucine, 0.2942 mM L-tyrosine, 0.2241 mM
L-threonine, 0.3227 mM L-phenylalanine, 0.1721 mM L-histidine, 0.71 mM L-glycine, 0.1307 mM
L-tryptophan, 0.2036 mM L-isoleucine, and 0.1789 mM L-methionine.
(a) a unit of totipotent plant tissue; and (h) a nutritive medium comprising 0 g/L to 30 g/L gel solute, 2.5 g/L
charcoal, 146.07 mM sucrose, 13.32 mM urea, 3.74 mM NH4NO3, 13.23 mM KH2PO4, 1.54 mM CaCl2, 1.98 mM
MgSO4, 0.245 mM ferric citrate, 0.162 mM H3BO3, 0.0023 mM CuCl2, 0.0003 mM
(NH4)2MoO4, 0.0012 mM thiamine.HCl, 0.0003 mM riboflavin, 0.0012 mM pyridoxine.HCl, 0.001 mM
Ca-pantothenate, 0.0081 mM nicotinic acid, 4.09x10-6 mM biotin, 0.0003 mM
folic acid, 0.555 mM
myo-inositol, 0.8076 mM L-asparagine, 1.8248 mM L-glutamine, 0.1624 mM L-lysine, 0.7613 mM L-serine, 0.463 mM L-proline, 1.0471 mM L-arginine, 0.455 mM L-valine, 0.5983 mM
L-alanine, 0.6099 mM L-cysteine, 0.6099 mM L-leucine, 0.2942 mM L-tyrosine, 0.2241 mM
L-threonine, 0.3227 mM L-phenylalanine, 0.1721 mM L-histidine, 0.71 mM L-glycine, 0.1307 mM
L-tryptophan, 0.2036 mM L-isoleucine, and 0.1789 mM L-methionine.
25. A manufactured seed, comprising:
(a) a unit of totipotent plant tissue; and (b) a nutritive medium comprising at least 15 components selected from the group consisting of: 10 g/L to 25 g/L gel solute, 25 mM to 175 mM carbon source, 10 mM to 15 mM
KNO3, 2 mM to 4 mM NH4NO3, 0.002 mM to 0.005 mM KI, 0.05 mM to 18 mM KH2PO4, 1 mM
to 3 mM CaCl2, 0.2 mM to 3 mM MgSO4, 0.01 mM to 0.8 mM Na2EDTA, 0.01 mM to 0.05 mM
FeSO4, 0.02 mM to 0.5 mM MnSO4, 0.1 mM to 0.5 mM H3BO3, 0.0003 mM to 0.004 mM
ZnSO4, 1x10-5 mM to 1x10-4 mM CoCl2, 1x10-5 mM to 1x10-4 mM CuSO4, 1x10-4 mM to 0.001 mM
Na2MoO4, 0.001 mM to 0.005 mM thiamine.HCI, 0.001 mM to 0.004 mM
pyridoxine.HCl, 0.001 mM to 0.01 mM nicotinic acid, 0.1 mM to 1 mM myo-inositol, and 0.01 mM to 0.1 mM
L-glycine.
(a) a unit of totipotent plant tissue; and (b) a nutritive medium comprising at least 15 components selected from the group consisting of: 10 g/L to 25 g/L gel solute, 25 mM to 175 mM carbon source, 10 mM to 15 mM
KNO3, 2 mM to 4 mM NH4NO3, 0.002 mM to 0.005 mM KI, 0.05 mM to 18 mM KH2PO4, 1 mM
to 3 mM CaCl2, 0.2 mM to 3 mM MgSO4, 0.01 mM to 0.8 mM Na2EDTA, 0.01 mM to 0.05 mM
FeSO4, 0.02 mM to 0.5 mM MnSO4, 0.1 mM to 0.5 mM H3BO3, 0.0003 mM to 0.004 mM
ZnSO4, 1x10-5 mM to 1x10-4 mM CoCl2, 1x10-5 mM to 1x10-4 mM CuSO4, 1x10-4 mM to 0.001 mM
Na2MoO4, 0.001 mM to 0.005 mM thiamine.HCI, 0.001 mM to 0.004 mM
pyridoxine.HCl, 0.001 mM to 0.01 mM nicotinic acid, 0.1 mM to 1 mM myo-inositol, and 0.01 mM to 0.1 mM
L-glycine.
26. The manufactured seed of claim 25, wherein the nutritive medium further comprises 0 to 5 g/L charcoal.
27. The manufactured seed of claim 25, wherein the nutritive medium further comprises a non-protein amino acid.
28. The manufactured seed of claim 27, wherein the non-protein amino acid is ornithine.
29. The manufactured seed of claim 25, wherein the carbon source is sucrose.
30. The manufactured seed of claim 25, wherein the nutritive medium further comprises a smoke suspension.
31. The manufactured seed of claim 25, wherein the nutritive medium further comprises a polyamine selected from the group consisting of putrescine, spermidine, spermine, and mixtures thereof.
32. The manufactured seed of claim 25, wherein the nutritive medium further comprises riboflavin.
33. The manufactured seed of claim 25, wherein the nutritive medium further comprises Ca-pantothenate.
34. The manufactured seed of claim 25, wherein the nutritive medium further comprises biotin.
35. The manufactured seed of claim 25, wherein the nutritive medium further comprises folic acid.
36. The manufactured seed of claim 25, wherein the nutritive medium further comprises an oxygen-absorbing substance.
37. A manufactured seed comprising:
(a) a unit of totipotent plant tissue; and (b) a nutritive medium comprising at least 15 components selected from a group consisting of: 10 g/L to 25 g/L gel solute, 25 mM to 175 mM carbon source, 10 mM to 15 mM
KNO3, 2 mM to 4 mM NH4NO3, 0.002 mM to 0.005 mM KI, 0.05 mM to 18 mM KH2PO4, 1 mM to 3 mM
CaCl2, 0.2 mM to 3 mM MgSO4, 0.01 mM to 0.8 mM Na2EDTA, 0.01 mM to 0.05 mM
FeSO4, 0.02 mM to 0.5 mM MnSO4, 0.1 mM to 0.5 mM H3BO3, 0.0003 mM to 0.004 mM ZnSO4, 1x10-5 mM to 1x10-4 mM CoCl2, 1x10-5 mM to 1x10-4 mM CuSO4, 1x10-4 mM to 0.001 mM
Na2MoO4, 0.001 mM to 0.005 mM thiamine.HCI, 0.001 mM to 0.004 mM pyridoxine.HCl, 0.001 mM to 0.01 mM nicotinic acid, 0.1 mM to 1 mM myo-inositol, 5 mM to 20 mM urea, 0.1 mM to 0.4 mM
ferric citrate, 0.01 mM to 0.05 mM MnCl2, 0.001 mM to 0.005 mM CuCl2. 1x10-4 mM to 1x10-3 mM (NH4)2MoO4, 1x10-4 mM to 1x10-3 mM riboflavin, 0.0005 mM to 0.015 mM Ca-pantothenate, 1x10-7 mM to 1x10-5 mM biotin, 1x10-4 mM to 1x10-3 mM folic acid; and at least one component selected from the group consisting of: 0.01 mM to 0.1 mM L-glycine, 0.01 mM to 1 mM
L-asparagine, 0.01mM to 3 mM L-glutamine, 0.01 mM to 1 mM L-lysine, 0.01 mM to 1 mM
L-serine, 0.01 mM to 1 mM L-proline, 0.01 mM to 4 mM L-arginine, 0.01 mM to 1 mM L-valine, 0.01 mM to 1 mM L-alanine, 0.01 mM to 1 mM L-cysteine, 0.01 mM to 1 mM L-leucine, 0.01 mM to 1 mM L-tyrosine, 0.01 mM to 1 mM L-threonine, 0.01 mM to 1 mM L-phenylalanine, 0.01 mM to 1 mM L-histidine, 0.01 mM to 0.1 mM L-glycine, 0.01 mM to 1 mM L-tryptophan, 0.01 mM to 1 mM L-isoleucine, and 0.01 mM to 1 mM L-methionine.
(a) a unit of totipotent plant tissue; and (b) a nutritive medium comprising at least 15 components selected from a group consisting of: 10 g/L to 25 g/L gel solute, 25 mM to 175 mM carbon source, 10 mM to 15 mM
KNO3, 2 mM to 4 mM NH4NO3, 0.002 mM to 0.005 mM KI, 0.05 mM to 18 mM KH2PO4, 1 mM to 3 mM
CaCl2, 0.2 mM to 3 mM MgSO4, 0.01 mM to 0.8 mM Na2EDTA, 0.01 mM to 0.05 mM
FeSO4, 0.02 mM to 0.5 mM MnSO4, 0.1 mM to 0.5 mM H3BO3, 0.0003 mM to 0.004 mM ZnSO4, 1x10-5 mM to 1x10-4 mM CoCl2, 1x10-5 mM to 1x10-4 mM CuSO4, 1x10-4 mM to 0.001 mM
Na2MoO4, 0.001 mM to 0.005 mM thiamine.HCI, 0.001 mM to 0.004 mM pyridoxine.HCl, 0.001 mM to 0.01 mM nicotinic acid, 0.1 mM to 1 mM myo-inositol, 5 mM to 20 mM urea, 0.1 mM to 0.4 mM
ferric citrate, 0.01 mM to 0.05 mM MnCl2, 0.001 mM to 0.005 mM CuCl2. 1x10-4 mM to 1x10-3 mM (NH4)2MoO4, 1x10-4 mM to 1x10-3 mM riboflavin, 0.0005 mM to 0.015 mM Ca-pantothenate, 1x10-7 mM to 1x10-5 mM biotin, 1x10-4 mM to 1x10-3 mM folic acid; and at least one component selected from the group consisting of: 0.01 mM to 0.1 mM L-glycine, 0.01 mM to 1 mM
L-asparagine, 0.01mM to 3 mM L-glutamine, 0.01 mM to 1 mM L-lysine, 0.01 mM to 1 mM
L-serine, 0.01 mM to 1 mM L-proline, 0.01 mM to 4 mM L-arginine, 0.01 mM to 1 mM L-valine, 0.01 mM to 1 mM L-alanine, 0.01 mM to 1 mM L-cysteine, 0.01 mM to 1 mM L-leucine, 0.01 mM to 1 mM L-tyrosine, 0.01 mM to 1 mM L-threonine, 0.01 mM to 1 mM L-phenylalanine, 0.01 mM to 1 mM L-histidine, 0.01 mM to 0.1 mM L-glycine, 0.01 mM to 1 mM L-tryptophan, 0.01 mM to 1 mM L-isoleucine, and 0.01 mM to 1 mM L-methionine.
38. The manufactured seed of claim 37, wherein the nutritive medium further comprises 0 to 5 g/L charcoal.
39. The manufactured seed of claim 37, wherein the nutritive medium further comprises a non-protein amino acid.
40. The manufactured seed of claim 39, wherein the non-protein amino acid is ornithine.
41. The manufactured seed of claim 37, wherein the carbon source is sucrose.
42. The manufactured seed of claim 37, wherein the nutritive medium further comprises a smoke suspension.
43. The manufactured seed of claim 37, wherein the nutritive medium further comprises a polyamine selected from the group consisting of putrescine, spermidine, spermine, and mixtures thereof.
44. A nutritive medium, comprising: 58.43 mM sucrose, 11.57 mM KNO3, 2.577 mM
NH4NO3, 0.0025 mM KI, 0.625 mM KH2PO4, 1.133 mM CaCI2, 0.367 mM MgSO4, 0.05 mM
Na2EDTA, 0.027 mM FeSO4, 0.045 mM MnSO4, 0.05 mM H3BO3, 8.4x10-3 mM ZnSO4, 3.2x10-5 mM CuSO4, 2.9x10-5 mM CoCl2, 4.4x10-4 mM Na2MoO4, 0.003 mM thiamine.HCl, 0.0024 mM
pyridoxine.HCl, 0.0041 mM nicotinic acid, 0.555 mM myo-inositol, and 0.027 mM
L-glycine.
NH4NO3, 0.0025 mM KI, 0.625 mM KH2PO4, 1.133 mM CaCI2, 0.367 mM MgSO4, 0.05 mM
Na2EDTA, 0.027 mM FeSO4, 0.045 mM MnSO4, 0.05 mM H3BO3, 8.4x10-3 mM ZnSO4, 3.2x10-5 mM CuSO4, 2.9x10-5 mM CoCl2, 4.4x10-4 mM Na2MoO4, 0.003 mM thiamine.HCl, 0.0024 mM
pyridoxine.HCl, 0.0041 mM nicotinic acid, 0.555 mM myo-inositol, and 0.027 mM
L-glycine.
45. A nutritive medium, comprising: 2.5 g/L charcoal, 146.07 mM sucrose, 13.32 mM
urea, 3.74 mM NH4NO3, 1.98 mM MgSO4, 0.019 MnCl2, 0.0016 ZnSO4, 13.23 mM
KH2PO4, 1.54 mM CaCl2, 0.245 mM ferric citrate, 0.162 mM H3BO3, 0.0023 mM CuCl2, 0.0003 mM
(NH4)2MoO4, 0.0012 mM thiamine.HCl, 0.0003 mM riboflavin, 0.0012 mM
pyridoxine.HCl, 0.0010 mM Ca-pantothenate, 0.0081 mM nicotinic acid, 4.09x10-6 mM biotin, 0.0003 mM folic acid, 0.555 mM myo-inositol, 0.8076 mM L-asparagine, 1.8248 mM L-glutamine, 0.1624 mM
L-lysine, 0.7613 mM L-serine, 0.4630 mM L-proline, 1.0471 mM L-arginine, 0.4550 mM L-valine, 0.5983 mM L-alanine, 0.6099 mM L-cysteine, 0.6099 mM L-leucine, 0.2942 mM L-tyrosine, 0.2241 mM L-threonine, 0.3227 mM L-phenylalanine, 0.1721 mM L-histidine, 0.7100 mM
L-glycine, 0.1307 mM L-tryptophan, 0.2036 mM L-isoleucine, and 0.1789 mM L-methionine.
urea, 3.74 mM NH4NO3, 1.98 mM MgSO4, 0.019 MnCl2, 0.0016 ZnSO4, 13.23 mM
KH2PO4, 1.54 mM CaCl2, 0.245 mM ferric citrate, 0.162 mM H3BO3, 0.0023 mM CuCl2, 0.0003 mM
(NH4)2MoO4, 0.0012 mM thiamine.HCl, 0.0003 mM riboflavin, 0.0012 mM
pyridoxine.HCl, 0.0010 mM Ca-pantothenate, 0.0081 mM nicotinic acid, 4.09x10-6 mM biotin, 0.0003 mM folic acid, 0.555 mM myo-inositol, 0.8076 mM L-asparagine, 1.8248 mM L-glutamine, 0.1624 mM
L-lysine, 0.7613 mM L-serine, 0.4630 mM L-proline, 1.0471 mM L-arginine, 0.4550 mM L-valine, 0.5983 mM L-alanine, 0.6099 mM L-cysteine, 0.6099 mM L-leucine, 0.2942 mM L-tyrosine, 0.2241 mM L-threonine, 0.3227 mM L-phenylalanine, 0.1721 mM L-histidine, 0.7100 mM
L-glycine, 0.1307 mM L-tryptophan, 0.2036 mM L-isoleucine, and 0.1789 mM L-methionine.
46. A method for germinating a unit of totipotent plant tissue, comprising:
(a) providing a unit of totipotent plant tissue;
(b) providing a nutritive medium comprising at least 15 components selected from the group consisting of: 0g/L to 30 g/L gel solute, 5 mM to 200 mM carbon source, 0 mM to 20mM
KNO3, 2.5 mM to 5 mM NH4NO3, 0 mM to 0.01 mM KI, 0.01 mM to 20 mM KH2PO4, 0.5 mM
to 5 mM CaCl2, 0mM to 0.0001 mM CuSO4, 0.1 mM to 10 mM MgSO4, 0 mM to 0.1 mM
Na2EDTA, 0 mM to 0.1 mM FeSO4, 0 mM to 0.1 mM MnSO4, 0.01 mM to 1 mM H3BO3, 0.0001 mM to 0.005 mM ZnSO4, 0 mM to 0.0001 mM CoCl2, 0 mM to 0.001 mM Na2MoO4, 0 mM
to 0.01 mM thiamine.HCl, 0.001 mM to 0.005 mM pyridoxine.HCl, 0.001 mM to 0.02 mM
nicotinic acid, 0.05 mM to 2.5 mM myo-inositol, and 0.002 mM to 0.2 mM L-glycine;
(c) placing the totipotent plant tissue in functional contact with the nutritive medium in a manufactured seed; and (d) placing the manufactured seed in an environment conducive for plant growth so as to allow the plant tissue to grow and germinate from the manufactured seed.
(a) providing a unit of totipotent plant tissue;
(b) providing a nutritive medium comprising at least 15 components selected from the group consisting of: 0g/L to 30 g/L gel solute, 5 mM to 200 mM carbon source, 0 mM to 20mM
KNO3, 2.5 mM to 5 mM NH4NO3, 0 mM to 0.01 mM KI, 0.01 mM to 20 mM KH2PO4, 0.5 mM
to 5 mM CaCl2, 0mM to 0.0001 mM CuSO4, 0.1 mM to 10 mM MgSO4, 0 mM to 0.1 mM
Na2EDTA, 0 mM to 0.1 mM FeSO4, 0 mM to 0.1 mM MnSO4, 0.01 mM to 1 mM H3BO3, 0.0001 mM to 0.005 mM ZnSO4, 0 mM to 0.0001 mM CoCl2, 0 mM to 0.001 mM Na2MoO4, 0 mM
to 0.01 mM thiamine.HCl, 0.001 mM to 0.005 mM pyridoxine.HCl, 0.001 mM to 0.02 mM
nicotinic acid, 0.05 mM to 2.5 mM myo-inositol, and 0.002 mM to 0.2 mM L-glycine;
(c) placing the totipotent plant tissue in functional contact with the nutritive medium in a manufactured seed; and (d) placing the manufactured seed in an environment conducive for plant growth so as to allow the plant tissue to grow and germinate from the manufactured seed.
47. A method for germinating a unit of totipotent plant tissue, comprising:
(a) providing a unit of totipotent plant tissue;
(b) providing a nutritive medium comprising at least 15 components selected from the group consisting of: 0 g/L to 30 g/L gel solute, 0 g/L to 5 g/L charcoal, 5 mM
to 200 mM carbon source, 0 mM to 30 mM urea, 0 mM to 20 mM KNO3, 2.5 mM to 5 mM NH4NO3, 0 mM to 0.01 mM KI, 0.01 mM to 20 mM KH2PO4, 0.5 mM to 5 mM CaCl2, 0.1 mM to 10 mM MgSO4, 0 mM
to 0.1 mM Na2EDTA, 0 mM to 0.1 mM FeSO4, 0 mM to 0.5 mM ferric citrate, 0 mM
to 0.1 mM
MnSO4, 0 mM to 0.1 mM MnCl2, 0.01 mM to 1 mM H3BO3, 0.0001 mM to 0.005 mM
ZnSO4, 0 mM to 0.0001 mM CoCl2, 0 mM to 0.0001 mM CuSO4, 0 mM to 0.005 mM CuCl2, 0 mM
to 0.001 mM Na2MoO4, 0 mM to 0.001 mM (NH4)2MoO4, 0 mM to 0.01 mM thiamine.HCl, 0 mM to 0.001 mM riboflavin, 0.001 mM to 0.005 mM pyridoxine.HCl, 0 mM to 0.04 mM
Ca-pantothenate, 0.001 mM to 0.02 mM nicotinic acid, 0 mM to 1.0x10-5 mM
biotin, 0 mM to 0.001 mM folic acid, 0.05 mM to 2.5 mM myo-inositol; and at least one component selected from the group consisting of: 0 mM to 2 mM L-asparagine, 0 mM to 6 mM L-glutamine, 0 mM
to 2 mM
L-lysine, 0 mM to 2 mM L-serine, 0 mM to 2 mM L-proline, 0 mM to 8 mM L-arginine, 0 mM to 2 mM L-valine, 0 mM to 2 mM L-alanine, 0 mM to 2 mM L-cysteine, 0 mM to 2 mM L-leucine, 0 mM to 2 mM L-tyrosine, 0 mM to 2 mM L-threonine, 0 mM to 2 mM L-phenylalanine, 0 mM to 2 mM L-histidine, 0.002 mM to 0.2 mM L-glycine, 0 mM to 2 mM L-tryptophan, 0 mM to 2 mM
L-isoleucine, and 0 mM to 2 mM L-methionine;
(c) placing the totipotent plant tissue in functional contact with the nutritive medium in a manufactured seed; and (d) placing the manufactured seed in an environment conducive for plant growth so as to allow the plant tissue to grow and germinate from the manufactured seed.
(a) providing a unit of totipotent plant tissue;
(b) providing a nutritive medium comprising at least 15 components selected from the group consisting of: 0 g/L to 30 g/L gel solute, 0 g/L to 5 g/L charcoal, 5 mM
to 200 mM carbon source, 0 mM to 30 mM urea, 0 mM to 20 mM KNO3, 2.5 mM to 5 mM NH4NO3, 0 mM to 0.01 mM KI, 0.01 mM to 20 mM KH2PO4, 0.5 mM to 5 mM CaCl2, 0.1 mM to 10 mM MgSO4, 0 mM
to 0.1 mM Na2EDTA, 0 mM to 0.1 mM FeSO4, 0 mM to 0.5 mM ferric citrate, 0 mM
to 0.1 mM
MnSO4, 0 mM to 0.1 mM MnCl2, 0.01 mM to 1 mM H3BO3, 0.0001 mM to 0.005 mM
ZnSO4, 0 mM to 0.0001 mM CoCl2, 0 mM to 0.0001 mM CuSO4, 0 mM to 0.005 mM CuCl2, 0 mM
to 0.001 mM Na2MoO4, 0 mM to 0.001 mM (NH4)2MoO4, 0 mM to 0.01 mM thiamine.HCl, 0 mM to 0.001 mM riboflavin, 0.001 mM to 0.005 mM pyridoxine.HCl, 0 mM to 0.04 mM
Ca-pantothenate, 0.001 mM to 0.02 mM nicotinic acid, 0 mM to 1.0x10-5 mM
biotin, 0 mM to 0.001 mM folic acid, 0.05 mM to 2.5 mM myo-inositol; and at least one component selected from the group consisting of: 0 mM to 2 mM L-asparagine, 0 mM to 6 mM L-glutamine, 0 mM
to 2 mM
L-lysine, 0 mM to 2 mM L-serine, 0 mM to 2 mM L-proline, 0 mM to 8 mM L-arginine, 0 mM to 2 mM L-valine, 0 mM to 2 mM L-alanine, 0 mM to 2 mM L-cysteine, 0 mM to 2 mM L-leucine, 0 mM to 2 mM L-tyrosine, 0 mM to 2 mM L-threonine, 0 mM to 2 mM L-phenylalanine, 0 mM to 2 mM L-histidine, 0.002 mM to 0.2 mM L-glycine, 0 mM to 2 mM L-tryptophan, 0 mM to 2 mM
L-isoleucine, and 0 mM to 2 mM L-methionine;
(c) placing the totipotent plant tissue in functional contact with the nutritive medium in a manufactured seed; and (d) placing the manufactured seed in an environment conducive for plant growth so as to allow the plant tissue to grow and germinate from the manufactured seed.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6623297P | 1997-11-20 | 1997-11-20 | |
| US60/066,232 | 1997-11-20 | ||
| PCT/US1998/024820 WO1999026470A1 (en) | 1997-11-20 | 1998-11-20 | Nutritive media and manufactured seeds comprising same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2309258A1 true CA2309258A1 (en) | 1999-06-03 |
| CA2309258C CA2309258C (en) | 2012-05-01 |
Family
ID=22068160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2309258A Expired - Fee Related CA2309258C (en) | 1997-11-20 | 1998-11-20 | Nutritive media and manufactured seeds comprising same |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU731857B2 (en) |
| CA (1) | CA2309258C (en) |
| NZ (1) | NZ505099A (en) |
| WO (1) | WO1999026470A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006094400A1 (en) * | 2005-03-10 | 2006-09-14 | Cellfor Inc. | Aerated liquid priming of conifer somatic germinants |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8466086B2 (en) | 1997-11-20 | 2013-06-18 | Weyerhaeuser Nr Company | Nutritive media and manufactured seeds comprising same |
| DE10011998A1 (en) * | 2000-03-11 | 2001-09-20 | Forschungszentrum Juelich Gmbh | Combination of active ingredients and methods for cultivating cells and methods for producing the combination of active ingredients |
| DE10130215B4 (en) | 2001-06-22 | 2007-08-30 | Hottinger Baldwin Messtechnik Gmbh | Measuring sensor with connected data memory |
| US7228658B2 (en) | 2003-08-27 | 2007-06-12 | Weyerhaeuser Company | Method of attaching an end seal to manufactured seeds |
| CA2486289C (en) | 2003-11-25 | 2008-01-08 | Weyerhaeuser Company | Combination end seal and restraint |
| US7555865B2 (en) | 2003-11-25 | 2009-07-07 | Weyerhaeuser Nr Company | Method and system of manufacturing artificial seed coats |
| CA2486311C (en) | 2003-11-26 | 2008-08-12 | Weyerhaeuser Company | Vacuum pick-up device with mechanically assisted release |
| US7795029B2 (en) * | 2003-12-04 | 2010-09-14 | Cellfor Inc. | Method of ex vitro sowing, germination, growth and conversion of plant somatic embryos or germinants |
| US7356965B2 (en) | 2003-12-11 | 2008-04-15 | Weyerhaeuser Co. | Multi-embryo manufactured seed |
| US7591287B2 (en) | 2003-12-18 | 2009-09-22 | Weyerhaeuser Nr Company | System and method for filling a seedcoat with a liquid to a selected level |
| US7568309B2 (en) | 2004-06-30 | 2009-08-04 | Weyerhaeuser Nr Company | Method and system for producing manufactured seeds |
| US7547488B2 (en) | 2004-12-15 | 2009-06-16 | Weyerhaeuser Nr Company | Oriented strand board panel having improved strand alignment and a method for making the same |
| US7654037B2 (en) | 2005-06-30 | 2010-02-02 | Weyerhaeuser Nr Company | Method to improve plant somatic embryo germination from manufactured seed |
| SI2522717T1 (en) | 2006-01-04 | 2014-05-30 | Baxter International Inc. | Oligopeptide-free cell culture media |
| AT503565B1 (en) * | 2006-06-16 | 2007-11-15 | Jhs Privatstiftung | PROCESS FOR THE PRODUCTION OF ORGANICALLY BOUND VITAMIN B |
| CA2713626C (en) | 2009-09-30 | 2013-11-19 | Weyerhaeuser Nr Company | Method to improve germination of embryos from manufactured seed |
| CA2713838C (en) | 2009-09-30 | 2014-12-02 | Weyerhaeuser Nr Company | Methods of preparing nutritive media for growth and/or germination of plant embryos |
| CA2713903C (en) * | 2009-09-30 | 2014-07-29 | Weyerhaeuser Nr Company | Nutritive media for use in manufactured seeds |
| RU2449525C2 (en) * | 2010-04-15 | 2012-05-10 | Анатолий Александрович Астахов | Agent for presowing seeds treatment, mostly sunflower (versions) |
| CN115380662B (en) * | 2022-10-27 | 2023-03-21 | 中国医学科学院药用植物研究所 | Seed coating method for improving drought resistance of isatis roots in seedling stage |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5427593A (en) * | 1990-10-26 | 1995-06-27 | Weyerhaeuser Company | Analogs of botanic seed |
| US5771632A (en) * | 1996-09-23 | 1998-06-30 | Liu; Sijiu | Artificial seed with a powder structure for anti-contamination |
-
1998
- 1998-11-20 CA CA2309258A patent/CA2309258C/en not_active Expired - Fee Related
- 1998-11-20 WO PCT/US1998/024820 patent/WO1999026470A1/en not_active Ceased
- 1998-11-20 AU AU15314/99A patent/AU731857B2/en not_active Ceased
- 1998-11-20 NZ NZ505099A patent/NZ505099A/en not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006094400A1 (en) * | 2005-03-10 | 2006-09-14 | Cellfor Inc. | Aerated liquid priming of conifer somatic germinants |
| US7923249B2 (en) | 2005-03-10 | 2011-04-12 | Cellfor Inc. | Aerated liquid priming of conifer somatic germinants |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2309258C (en) | 2012-05-01 |
| AU1531499A (en) | 1999-06-15 |
| AU731857B2 (en) | 2001-04-05 |
| NZ505099A (en) | 2002-03-01 |
| WO1999026470A1 (en) | 1999-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pittman et al. | Peptides and other nitrogen sources for growth of Bacteroides ruminicola | |
| Eagle | Amino acid metabolism in mammalian cell cultures | |
| Stuart et al. | Somatic embryogenesis from cell cultures of Medicago sativa LI The role of amino acid additions to the regeneration medium | |
| CN101902907B (en) | Use of a fertilizer containing L-amino acid for improving root growth and growth of mycorrhiza | |
| Lewis et al. | Plants and nitrogen | |
| GB2051075A (en) | Plasminogen activator | |
| CA2309258C (en) | Nutritive media and manufactured seeds comprising same | |
| CN106635953B (en) | Serum-free and protein-free cell culture medium | |
| Hawkins et al. | The costs of cell volume regulation: protein metabolism during hyperosmotic adjustment | |
| CA2332701A1 (en) | Medium and matrix for long-term proliferation of cells | |
| RU2005138717A (en) | METHOD FOR PRODUCING DIPEPTIDE (OPTIONS) | |
| Altman et al. | Interactions of polyamines and nitrogen nutrition in plants | |
| Pichereau et al. | The osmoprotectant glycine betaine inhibits salt-induced cross-tolerance towards lethal treatment in Enterococcus faecalis | |
| WO2005021596A3 (en) | Compositions and methods for glycogen synthesis | |
| WO2008081582A1 (en) | Packed drink | |
| CA2231148A1 (en) | Composition for an in vitro fertilization medium | |
| RU99106547A (en) | DETERMINATION OF EXTRACELLULAR CONCENTRATIONS OF CISTEINE AND GLUTATHION | |
| FI4043551T3 (en) | Nutrient media for cell culture containing plant protein hydrolysates | |
| CN107236708A (en) | A kind of serum free medium for supporting HeLa cell attachment cultures | |
| Durzan | Nitrogen metabolism and vegetative propagation of forest trees | |
| JP7175907B2 (en) | Medium containing dipeptide | |
| RU99100621A (en) | BIOCHEMICAL DETERMINATION OF ANTIOXIDANT FUNCTION | |
| Balasubramanian et al. | Nutrient media for plant-parasitic nematodes: II. Amino acid requirements of Aphelenchoides sp. | |
| CA1310928C (en) | Herbicide-resistant crop plants, process for their selection and theirregeneration | |
| US6709481B2 (en) | Method for the production of a unique soil adjuvant for horticultural and agronomic use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20181120 |